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Background: Monitoring the scale of pharmaceuticals, illicit and licit drugs consumption is important to assess the
needs of law enforcement and public health, and provides more information about the different trends within
different countries. Community drug use patterns are usually described by national surveys, sales and seizure data.
Wastewater-based epidemiology (WBE) has been shown to be a reliable approach complementing such surveys.
Method: This study aims to compare and correlate the consumption estimates of pharmaceuticals, illicit drugs,
alcohol, nicotine and caffeine from wastewater analysis and other sources of information. Wastewater samples were
collected in 2015 from 8 different European cities over a one week period, representing a population of
approximately 5 million people. Published pharmaceutical sale, illicit drug seizure and alcohol, tobacco and caffeine
use data were used for the comparison.
Results: High agreement was found between wastewater and other data sources for pharmaceuticals and cocaine,
whereas amphetamines, alcohol and caffeine showed a moderate correlation. methamphetamine and 3,4-
methylenedioxymethamphetamine (MDMA) and nicotine did not correlate with other sources of data. Most of the
poor correlations were explained as part of the uncertainties related with the use estimates and were improved
with other complementary sources of data.
Conclusions: This work confirms the promising future of WBE as a complementary approach to obtain a more
accurate picture of substance use situation within different communities. Our findings suggest further
improvements to reduce the uncertainties associated with both sources of information in order to make the data
more comparable.
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The chemical analysis of the exogenous biomarkers of
drug consumption in wastewater has been shown to be an
interesting approach for studying drug use within a de-
fined population [1]. The approach, termed wastewater-
based epidemiology (WBE), was first applied in 2008 to
study illicit drug use in three Italian cities [2] and it has
since been extended to a wider range of exogenous bio-
markers specific to the use of alcohol [3–5], tobacco [6],
caffeine [7] and selected pharmaceuticals [8, 9]. To date
there has been very limited focus on evaluating the rela-
tionship between WBE data to other drug use measures.
The use of pharmaceuticals in society is usually deter-
mined by prescription data or self-reports. However,
pharmaceutical prescription or sales data involve several
sources of uncertainties such as the inappropriate use of
a medication, household disposal through the toilet or
sink, sales without prescription or illegal acquisition
[10–12]. Self-reports on adherence are potentially sub-
ject to recall and reporter bias [13]. An alternative could
be to quantitatively measure pharmaceuticals in waste-
water as an indicator of use [14–16].
Europe has a significant market for illicit drugs sus-
tained by both domestic production and import from
other regions [17]. Different monitoring approaches have
been used to investigate the scale of drug use. Police and
custom’s seizures, population surveys, hospital admissions,
drug-overdose deaths or treatment programs have been
the most reliable data for drug use estimates [18–20].
Under-reporting is still apparent despite the use of a num-
ber of different sources of information to improve the
level of accuracy of self-reporting [21]. Seizure data may
not give the correct picture and surveys suffer from
reporting biases and low response rates [22]. WBE has
been introduced as a promising alternative or addition to
these sources of data [23–25].
There is also a need to be able to accurately determine
the consumption of licit drugs, such as alcohol, nicotine
and caffeine. Alcohol consumption can be estimated from
sales statistics but trafficking, illegal production, stock pil-
ing or waste can affect such data. Reid and co-workers for
the first time applied WBE to obtain complementary
information on community alcohol consumption by ana-
lysing the alcohol metabolite, ethyl sulfate (EtS) in waste-
water [4]. This approach has since been used in other
studies to report the rates of alcohol consumption in pop-
ulations [3, 26], but the value of these biomarkers has yet
to be determined. Tobacco use is commonly deduced
from tobacco sales statistics. Prevalence surveys and the
aggregate between production and trade statistics can also
yield the total consumption estimates [27]. However, these
data may bias the total consumption estimates (similar to
alcohol) indicating that additional methods are required in
order to improve tobacco use estimations. WBE has alsobeen used to determine nicotine use through the measure-
ment of its residues in wastewater at national level [6, 7, 28].
These data were compared with local tobacco sales statistics
finding good agreement [29]. Caffeine is present in coffee
and tea as well as other products such as energy drinks,
chocolate and certain medicines. Caffeine occurrence has
been investigated to assess its patterns of use across different
communities [7, 30].
Very few studies to date have correlated wastewater
data with other sources of data. So far, pharmaceutical
concentrations in wastewater have been related to the
amounts used in a population by using prescription data
[11, 31–33]. A Spanish study compared wastewater con-
centrations of 17 pharmaceuticals with annual sales data
and found a good correlation [31]. The same was true
for studies from Australia [32], Italy [33], and Belgium
[11]. One study compared cocaine loads in wastewater
in Oslo with cocaine measures from population survey
data and drug tests among car drivers and found a good
correlation [21]. A recent study in Belgium compared
WBE results with survey data collected simultaneously
in a small community of around 30,000 inhabitants for
alcohol and nicotine metabolites [34]. No significant
correlations were found, but the study was impaired by a
typically low response to the surveys. Discrepancies
between wastewater and national survey data have also
been found in Australia [35].
The present study aims to compare WBE data with
other sources of drug use data in order to assess its correl-
ation. The study uses concentrations of pharmaceuticals,
illicit drugs, alcohol, nicotine and caffeine in wastewater
samples from different European cities and compares
these with other sources of data for drug use. The data
used for comparison were pharmaceutical prescriptions
(morphine, methadone, atenolol, metoprolol, methylphen-
idate, carbamazepine, citalopram, paracetamol, oxazepam
and diclofenac), police drug seizure data for illicit drugs
(cocaine, amphetamine, and MDMA (ecstasy)), and con-
sumption data for alcohol, tobacco and caffeine metabo-
lites (EtS; cotinine, nicotine and hydroxycotinine; caffeine,
paraxanthine, 1-methylxanthine, 7-methylxanthine, 1-
methyluric acid and 1,7-dimethyluric acid).
Methods
Wastewater samples
Twenty-four hour composite inlet sewage samples were
collected from 8 different European wastewater treatment
plants (WWTP) over 7 consecutive days in March 2015.
All samples were stored in plastic containers, immediately
frozen at −20 °C to prevent degradation of the urinary me-
tabolites and sent to Oslo and Milan within 24 h in cool
boxes with dry ice or ice packs to keep the samples frozen.
The average wastewater flow rate (litres per day (L/day))
through each of the treatment plants was recorded for
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morning between 07:00 and 8:30 except for Zurich where
it was performed at 00:00 (see sample details in Additional
file 1: Table S1).
Extraction and analysis
The analysis of the different wastewater samples was
performed using three previously validated methods
[4, 7, 9]. Illicit drugs and pharmaceuticals were analysed
by liquid chromatography coupled to quadrupole time-
of-flight mass spectrometry (LC-QTOF) as described by
Baz-Lomba and co-workers [9]. Briefly, 50 ng of the
isotopic labelled internal standards (ILIS) solution mix
was spiked into wastewater (100 mL) and then extracted
on a fully automatable solid phase extraction (SPE)
(Horizon Technology, Salem, NH, USA) with HLB
extraction disks (47 mm, I.D.; Horizon Technology, City,
Country). 5 μL of the final eluent were injected into the
LC-QTOF system. The compounds were chromato-
graphically separated on a Waters Acquity UPLC system
(Milford, MA, USA) fitted with a Acquity UPLC HSS C18
column (1.8 μm, 2.1 mm × 150 mm) (Waters, Milford,
MA, USA). A Xevo G2-S Q-TOF mass spectrometer
(Waters, Milford, MA USA) was used in positive ESI
mode for acquisition using MSe, that allows both
precursor and product ion data to be simultaneously
acquired during a single run. Analyses were performed
using an external reference (Lock-Spray™) with Leucine-
enkephalin generating a reference ion in positive mode at
m/z 556.2771 that was used for real-time mass corrections
in order to maintain the mass accuracy.
EtS was analysed by ion-pair liquid chromatography
coupled to tandem mass spectrometry (ion-pair LC-MS/
MS) as described by Reid and co-workers [4]. Briefly, an
aliquot (1 ml) of each sample was spiked with deuterated
internal standard (EtS-d5) at 50 ng/mL and centrifuged
at 20,000 g for 10 mins. The supernatant was subse-
quently injected into the LC-MS/MS system (Waters,
Milford, MA) equipped with an Acquity UPLC BEH C8
column (1.7 μm, 2.1 mm × 50 mm) (Waters, Milford,
MA, USA). Mobile phases were 7 mM dihexylammo-
nium acetate in water and methanol prepared by adding
equimolar volumes of dihexylamine and acetic acid into
the solvents.
The tobacco and coffee biomarkers were analysed by
liquid chromatography-tandem mass spectrometry (LC–
MS/MS) (API 5500 QqQ. Applied Biosystems-Sciex,
Thornhill, Ontario, Canada) [7]. Wastewater samples were
filtered through 1.6 μm GF/A glass microfiber filters and
0.45 μm mixed cellulose membrane filters purchased from
Whatman (Kent, UK). An aliquot (3 mL) was spiked with
the mix labelled internal standard solution and loaded into
the Oasis HLB SPE cartridges. For analysis, the extract
was evaporated to dryness and reconstituted in 100 μLmethanol-ultrapure water (20:80, v/v), centrifuged and
transferred into glass vials for instrumental analysis. Fi-
nally, 1 μL of the final extract were injected in a LC–MS/
MS system. Chromatographic separation was performed
using a HPLC XTerra C18 column (3.5 μm, 1 mm ×
100 mm) (Waters, Milford, MA, USA) and analytes were
ionized using electrospray ionization in positive mode.
Calculations
Drug consumption in the population connected to the
respective WWTP was calculated by multiplying the
measured concentration (Cww) of each compound (ng/L)
by the average daily flow rate (qday) (m
3/day) to obtain
the daily mass loads (mg/day). Mass loads were then di-
vided by the population served within the catchment
area (Pww) to obtain the amount of the drug consumed
per day per 1000 inhabitants expressed as population-
normalised mass loads (Eq. 1). Correction factors (kCF)
to account for the different excretion patterns were used
only for pharmaceuticals. Moreover, concentration
values that were < LOQ (method limit of quantification)
were replaced by LOQ/2 if at least one day in the week
had a concentration value above the LOQ [36].
Population‐normalised mass loads in WW ¼ Cww x qday x kCF
1000 x Pww=1000ð Þ ¼
mg=day
1000 inh
 Pharmaceuticals: Wastewater analysis vs sales data
The environmental population-normalised loads for
the selected pharmaceuticals in wastewater were esti-
mated for Oslo (Norway) from the per capita monthly
sales data from 2012 and 2013 (Norwegian Drug Whole-
sales statistics, Norwegian Institute of Public Health).
Norway has one of the most accurate national prescrip-
tion and sales systems in the world and all data are elec-
tronically available [37]. The possibility of gathering the
sales data for the area of interest decreases the level of
uncertainty. Other studies [31, 33] used national-based
data and assumed that consumption pattern was the
same for the whole national population.
VEAS, the Oslo WWTP, treats sewage for around
600,000 people of which Oslo contributes with the 70.5 %
and Akershus with the 29.5 % (8 % from Asker and 21.5 %
from Bærum). The monthly sales data (gathered for Oslo
and Akershus) from 2012 and 2013 remain constant for
all the pharmaceuticals during the course of the two years.
For the calculation of the predicted loads the amount of
defined daily doses (DDD) for each pharmaceutical was
multiplied by the monthly turnover by dosage (TD) and
divided by the number of days of each month. The mea-
sured loads for the pharmaceuticals in wastewater were in
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into account the different urinary excretion rates.
 Illicit drugs: Wastewater analysis vs drug seizures
Measured population-normalised mass loads of benzoy-
lecgonine, total amphetamines (as a sum of amphetamine
and methamphetamine) and MDMA in wastewater were
compared with the seizure data available from the 2015
European Drug Report [17]. This report provided both the
number and amount of seizures in 2013 (most recent
data) for each substance except for Switzerland and the
Netherlands. Bramness and co-workers [38] recom-
mended the use of number of seizures for this kind of
comparison since it provides a more accurate description
of the drug situation rather than the amount seized which
is more vulnerable to variations. The correlations for the
three drugs are calculated based on the number of sei-
zures in 2013 as recommended previously, however,
further compared with the mean amount seized from
2010–2013 reported by the United Nations Office on
Drugs and Crime (UNODC).
 Legal stimulant drugs: Wastewater analysis vs sales
data
Three legal stimulants were measured for comparison
with sales and consumption. The alcohol consumption
rates measured in wastewater were compared with the
latest surveillance report on alcohol and health pub-
lished by the WHO (World Health Organization, 2014)
[39]. The WHO reported consumption rates for the
population aged 15 or older as L/year/person. Consump-
tion rates were corrected for the entire population and
then compared with the population-normalised loads of
EtS measured in the wastewater.
The measured population-normalised mass loads of
nicotine in wastewater were compared with tobacco
sales data (presented as number of cigarettes per
smoker per day) from 2014 as reported by the Tobacco
Atlas (Euromonitor International Database) [40]. These
data were normalised by multiplying the corresponding
correction factor for the percentage of population aged 15
or older. The mass loads for nicotine measured in waste-
water were calculated as suggested by Castiglioni and co-
workers [6] by summing up the loads of the two nicotine
main metabolites, cotinine and hydroxycotinine.
The population-normalised mass loads of caffeine and
its metabolites measured in wastewater were compared
with the per capita coffee consumption data from 2013
referred to the total dry weight of coffee consumed rather
than brewed volume (more sensitive to variations from
market to market) [41]. The correlation was performed
with two approaches, by comparing i) the consumptiondata with the mass loads of caffeine, and ii) the sum of the
six metabolites together. The interpretation of the waste-
water results for caffeine needs to be carefully addressed
since caffeine is present in many products, such as tea,
energy drinks and chocolate.
Statistics
Descriptive statistics for each data sources are presented
as means. Spearman’s correlation coefficient (ρ) was
used to assess the agreement between wastewater data
and pharmaceutical sales data, police seizures and sales
data, respectively for pharmaceuticals, illicit drugs and
legal stimulants. P values less than 0.05 were considered
statistically significant. All the analyses were performed
in R, Version 3.2.2 [42].
Results
Pharmaceuticals
Sales data for all of the targeted pharmaceuticals during
the 24 months between 2012 and 2013 remained con-
stant in Oslo. The coefficient of variation for sales varied
between 7 % (oxazepam) and 14 % (carbamazepine). All
of the selected pharmaceuticals were detected in all of
the wastewater samples collected from Oslo. Paraceta-
mol, metoprolol and carbamazepine showed the highest
mean population-normalised mass loads (11.2, 6.5 and
2.4 g/day/1000 inh. respectively), while methadone and
morphine were present at the lowest loads (19.0 and
94.2 mg/day/1000 inh. respectively). The day-to-day
variability for each of the compounds over 7 days was
relatively low with some exceptions (mean relative
standard deviation (RSD) = 24 %, excluding methadone,
morphine and methylphenidate). Methadone and mor-
phine loads varied considerably during the 7 days without
any pattern (RSD = 61 and 53 % respectively) while
methylphenidate showed a high RSD (93 %), mainly due
to the increased loads at the weekend.
A correction factor for the different urinary excretion
rates was applied to make the data comparable with the
pharmaceutical sales data for Oslo (Table 1). Sales data
for all of the targeted pharmaceuticals for the 24 months
between 2012 and 2013 remained constant in Oslo.
The coefficient of variation for sales varied between
7 % (oxazepam) and 14 % (carbamazepine). Spearman’s
rank correlation analysis was performed between the
sales data in Oslo and the results obtained from the
wastewater analysis for 10 different compounds show-
ing a significant correlation (ρ = 0.85, P < 0.01) (Fig. 1).
Illicit drugs
Benzoylecgonine was present in all of the wastewater
samples with population-normalised loads ranging be-
tween 151.5 (Oslo) and 672.6 mg/day/1000 inh. (Zurich)
determined. With the exception of Oslo, all of the loads
Table 1 Summary of the monthly average sales, amount of defined daily doses (DDD) and correction factors for the different
pharmaceuticals (reference)
Sales DDD Correction Loads based on sales data Loads measured in WW
Compound (monthly average) (g) factora (grams/day) (mg/day/1000 inh)
Atenolol 55770 0.07 2.7 [58] 139 215.7
Carbamazepine 18920 1 6.9 [59, 58] 631 2418.5
Citalopram 61708 0.02 9.6 [58] 41 267.2
Diclofenac 18920 0.1 8.3 [60] 588 961.3
Methadone 44698 0.02 3.6 [32] 37 19.0
Methylphenidate 80586 0.03 50.0 [61] 81 323.4
Metoprolol 347042 0.15 21.5 [58] 1735 6543.8
Morphine 14718 0.03 3.1 [2] 49 94.2
Oxazepam 89610 0.05 1.7 [62] 149 168.6
Paracetamol 471511 3 2.1 [58] 47151 11231.3
a Correction factor is based on the expected amount excreted in urine
Sales data average estimated over 24 months in 2012 and 2013. Population-normalised loads measured in wastewater data for pharmaceuticals in Oslo
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population-normalised loads for amphetamine and
methamphetamine found in wastewater from Oslo were
similar (122.3 and 172.4 mg/day/1000 inh., respect-
ively). Amphetamine was also measured in Bristol and
Utrecht while methamphetamine was measured in
Brussels, Milan, Zurich, Copenhagen, and at very low
concentrations in some of the samples from Castellon.
MDMA was detected in wastewater from all locations
but not in every sample. The mean daily population-
normalised loads for MDMA ranged from 5.4 mg/day/
1000 inh. for Castellon to 121.5 mg/day/1000 inh. for
Utrecht.
The measured wastewater loads for illicit drugs were
compared with national drug seizure data [17] (Table 2).
The lowest and highest number of cocaine seizures and
quantity seized in 2013 was in Norway and Spain
respectively. The Netherlands, Belgium and Italy also
reported large amounts of cocaine while the United
Kingdom reported the second highest number of seizures
within the studied countries. The reported seizures for
amphetamine were much higher in the United Kingdom.
In general all the countries reported similar values except
for Italy with very low number of seizures and amount
seized reported. The Netherlands and Switzerland did not
report data on amphetamine and methamphetamine. In
general, few seizures were reported on methampheta-
mine. Norway presented the highest total number of
seizures in 2013 (4,210 seizures) and mean amount
seized from 2010–2013 (161 kg/year). For MDMA, the
United Kingdom reported the highest number of sei-
zures in 2013 (3,716 seizures) while The Netherlands
the highest mean amount seized between 2010 and
2013 (1,750,867 tablets/year).Correlation analysis was performed between wastewa-
ter data measured in 2015 and the number of seizures
reported in 2013. The comparison for the illegal drugs
was performed using the most recent data available
(2015 European Drug Report with data from 2013 [17]).
As for pharmaceuticals, there was a time mismatch be-
tween both datasets, however, seizure trends remained
relatively stable during the last years. A significant
positive correlation was found between the measured
loads of benzoylecgonine and the number of seizures of
cocaine reported by the different countries (ρ = 0.89, P
= 0.03), while non-significant correlation was found be-
tween wastewater results and the number of seizures
for amphetamines (ρ = 0.49, P = 0.36) and MDMA (ρ =
0.26, P = 0.66). Wastewater data were also compared
with the mean amount seized from 2010–2013 reported
by the UNODC, but non-significant correlation was
found between the amount seized and the wastewater
data for cocaine, amphetamines and MDMA.
Alcohol, nicotine and caffeine
Table 3 shows the measured population-normalised
mass loads, sales and consumption data for the three
legal drugs studied; alcohol, nicotine and caffeine.
Copenhagen, Brussels and Oslo showed the highest EtS
population-normalised mass loads in wastewater (7.7,
5.6 and 4.9 g/day/1000 inh. respectively) while Castellon
and Milan showed the lowest level of alcohol use during
the wastewater study period (both with 1.7 g/day/1000
inh). The reported WHO alcohol consumption rates
were very similar for all the cities within a range of
11.9–14.1 L/year/person except for Italy and Norway,
which showed lower levels (7.8 and 9.5 L/year/person re-
spectively). Spearman’s rank correlation analysis showed,
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wastewater. Spearman’s correlation coefficient (ρ) was used to assess the level of agreement between wastewater and other sources of data. P values less
than 0.05 were considered statistically significant
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Table 2 Summary of the seizures and population-normalised loads measured in wastewater data for cocaine, amphetamines and MDMA
EMCDDA Drug Report 2015 UNODC Statistics Wastewater Analysis 2015
Number of seizures in 2013 Amount seized (2010–2013) Measured loads
(number/year) (kg/year) (mg/day/1000 inh)
City Cocaine Amphetamines MDMA Cocaine Amphetamines MDMAa Benzoylecgonine Amphetamines MDMA
Norway/Oslo 1086 7229 411 94 354 6468 151.5 294.7 37.7
Spain/Castellon 38033 3471 2301 20689 297 312780 463.9 0.8 5.4
Belgium/Brussels 3653 3085 1338 10127 197 40341 390.9 3.5 25.4
UK/Bristol 18569 6515 3716 3216 1223 494300 528.7 41.6 86.3
Netherlands/Utrecht - - - 10784 807 1750867 299.5 52.9 121.5
Italy/Milan 6031 128 136 5113 41 26311 380.9 10.4 15.5
Switzerland/Zurich - - - 307 40 23354 672.6 32.0 64.8
Denmark/Copenhagen 2286 2167 590 205 275 35430 337.2 11.7 53.1
a Number of tablets per year
Baz-Lomba et al. BMC Public Health  (2016) 16:1035 Page 7 of 11however no-correlation between the two data sources (ρ
= 0.53, P = 0.18).
The measured load profiles of nicotine in wastewater
varied among the 8 cities. The measurements in Oslo
showed the highest mass loads level with 4.0 g/day/1000
inh. followed by Zurich, Brussels and Castellon with 3.6,
3.1 and 3.1 g/day/1000 inh. respectively. Milan and Ut-
recht showed the lowest population-normalised mass
load rates (1.5 and 1.3 g/day/1000 inh. respectively).
These data have been compared with tobacco consump-
tion estimates provided by The Tobacco Atlas [40]. The
Tobacco Atlas reports Belgium as the country with the
highest consumption rate of cigarettes (7.8 cigarettes/
person/day) whereas Norway is reported as the country
with the lowest rate (1.9 cigarettes/person/day). However,Table 3 Summary of consumption estimates and population-norma
and caffeine
Alcohol Tobacco
Reported Wastewater Reported
WHO EtS Euromonitor Int.
City/Country (L/year/person.) c(g/day/1000 inh) (cigarettes/person/d
Oslo/Norway 9.5 4.9 1.5
Castellon/Spain 13.2 1.7 4.8
Brussels/Belgium 13.3 5.6 4.0
Bristol/UK 14.1 4.2 2.1
Utrecht/
Netherlands
11.9 2.8 2.2
Milan/Italy 7.8 1.7 4.0
Zurich/
Switzerland
12.6 3.8 4.7
Copenhagen/
Denmark
13.9 7.7 3.9our analysis showed a non-significant correlation between
the two data sources (ρ = −0.09, P = 0.84).
Oslo had the highest measured population-normalised
loads for caffeine with a value of 42.9 g/day/1000 inh.
followed by Copenhagen and Brussels with 39.4 and
25.8 g/day/1000 inh. respectively. By summing up all the
caffeine metabolites Oslo still had a high mass load rates
(129.7 g/day/1000 inh.), but Zurich and Copenhagen
with 141.0 and 154.1 g/day/1000 inh. respectively were
reported as the highest. There was no significant correl-
ation between the measured loads of caffeine in waste-
water and the caffeine consumption rates (ρ = 0.64, P =
0.09). The sum of all the caffeine metabolites measured
in wastewater did not provide a better correlation (ρ =
0.33, P = 0.42).lised loads measured in wastewater data for alcohol, tobacco
Caffeine (Coffee)
Wastewater Reported Wastewater
HydCot + Cot Euromonitor Int. Caffeine Sum
Metabolites
ay) (g/day/1000 inh.) (kg per capita in 2013.) g/day/1000 inh
6.7 7.2 42.9 129.7
5.2 3.0 9.9 74.2
5.3 4.9 25.8 116.6
3.4 1.7 22.1 112.8
2.1 6.7 13.4 57.3
2.6 3.4 10.8 49.9
6.0 3.9 24.5 141.0
2.1 5.3 39.4 154.1
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This study compared the population-normalised mass
loads of three different groups of compounds measured
in wastewater with other drug use data sources. The
pharmaceutical consumption was compared at local
level in Oslo (Norway) while the comparison between
wastewater data and other sources of data for the illicit
and legal stimulant drugs was performed at international
level. The wastewater data for the pharmaceuticals and
also cocaine showed a high correlation with other data
sources for use. For amphetamines, alcohol and caffeine
a moderate, but non-significant correlation was ob-
served, while wastewater data on MDMA and nicotine
did not correlate with other sources of data.
The correlation between wastewater data for pharma-
ceuticals and sales data corroborates the findings of an
earlier study finding good agreement between the sales
data of metoprolol and cetirizine and measured loads of
these drugs in wastewater in Oslo [43]. In addition, the
pharmaceuticals wholesale data used in the current
study were from Oslo only and extracted only for the
month of interest. Hence, the accuracy may be higher
than national consumption data [31–33], which does
take into consideration different local patterns of use
[11], or prescription databases that may miss the contri-
butions from hospital in-patients and sales of over-the-
counter drugs [44]. The current results seem to suggest
that WBE data represent accurately the population drug
use that is usually measured by sales data, confirming
that wastewater data could be used with certainty to es-
timate drug use in a population.
Among the studied illicit drugs, cocaine measurements
in wastewater showed the best agreement with seizure
data. The wastewater results for cocaine further agree with
the latest WBE multi-city study performed in Europe in
2014 in which United Kingdom, The Netherlands,
Belgium, Switzerland and Spain reported the highest
population-normalised loads in 2014 [45]. In the same
study, Utrecht and Castellon showed the lowest national
population-normalised loads of cocaine measured in
wastewater for their respective countries. These national
spatial differences can explain some of the discrepancies
between the WBE and the national seizure data.
For all the other comparisons in the present study the
relationship between wastewater data and other sources of
drug use data were less than optimal. Wastewater data
presents intra-country and spatial variability and the pat-
terns of drug use also vary over the course of the year
[24], while seizures and consumption data represents an
annual average within the whole country. WBE results
have already shown different patterns of drug use within
the same country [23, 45]. For many of our analysis we
had very few observations making it possible for spurious
measures to influence the analysis unduly. Moreover, thedifferent sources of data may not compare because they
measure different things (E.g. number of seizures and
amount seized data did not agree completely, but together
may improve the general picture of the drug situation in
Europe describing the main points of entrance and pos-
sible trafficking distribution). In an Australian study the
wastewater data was contrary to the drug use surveys but
in agreement with prevalence data, police, health agencies
and the media [35]. The negative results should thus be
interpreted carefully.
The sum of the amphetamine and methamphetamine
measured mass loads in wastewater correlated only mod-
erately well with the number of seizures. A contributing
factor to the low agreement may be that amphetamines
have a more defined “geographical drug-use patterns” than
cocaine. While amphetamine is more usual in western
Europe, methamphetamine use is mainly concentrated in
northern Europe, Czech Republic and Slovakia [17]. This is
corroborated by previous WBE studies [23, 24, 38, 43, 46]
and prevalence data [17].
No relationship was observed between WBE data for
MDMA and the number of seizures. Despite this, waste-
water results seem to be in agreement with other stud-
ies. For example, Utrecht and Bristol showed the highest
population-normalised WBE loads of MDMA which is
in harmony with survey data from other sources [17].
MDMA is however a drug used more typically on special
occasions and as a “party drug”, making it more sensitive
to timing of WBE [47]. Also, the MDMA market has
changed dramatically during the last couple of years [17]
and our poor results may have been worsened by the
fact that we compared wastewater results from 2015
with seizures data from 2013. Furthermore, we only had
six observations due to lack of seizure data from some
countries [24].
Only a moderate correlation was found between EtS
loads in wastewater and WHO sales data corroborating
other studies finding similar discrepancies. A study from
Santiago de Compostela and Milan estimated alcohol
use on wastewater data and found results 39 and 68 %
lower than the estimates reported by the WHO [3]. A
Belgian study found that WBE data for alcohol con-
sumption were in agreement with values reported by the
Belgian Scientific Institute of Public Health, but much
lower than those reported by the WHO [5]. Lastly, a
multi-city international study of alcohol consumption
for 20 different cities showed that a significant correl-
ation was found for only 11 cities between the WHO
estimations and the wastewater measurements [48]. Ac-
cording to these studies the main limitations are related
to suboptimal records over alcohol sales in many coun-
tries. The strict Norwegian government control over
alcohol sales results in accurate sales statistics [4]. Still,
the unregistered consumption of alcohol increased to
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hol loads measured in wastewater according to what ex-
pected by WHO [49]. In a previous study in Oslo, the
alcohol use estimates obtained from WBE and those re-
ported by the WHO were in good agreement [4]. This
indicates that WBE could be a suitable marker for alco-
hol consumption even with the observed moderate cor-
relation with consumption data.
No relationship was found between wastewater loads
for nicotine and cigarette sales data. Here Oslo appeared
to be an outlier. The popularity of dipping tobacco in
Norway has been shown to have risen between 2010–
2015, reaching the same prevalence levels as cigarettes
(10 % against the 13 % for cigarettes) [50]. The levels of
cotinine excreted from dipping tobacco users are in the
same range than cigarettes [51] which would induce an
overestimation when comparing wastewater with ciga-
rettes consumption data. In addition, a large amount of
dipping tobacco is disposed of into urinals and toilets
resulting in increased nicotine residues in Oslo´s waste-
water influent. Cigarette consumption may vary greatly
within countries [40] and other studies have shown a
better agreement when comparing WBE with smoking
prevalence data at regional level [6, 7, 29, 52]. Nicotine
metabolites have been proposed and used as quantitative
biomarkers to estimate population size at local level [7]
although the presented results and previous studies [53]
demonstrate that the different tobacco culture-dependent
and geographic behaviour may change between countries.
Therefore, nicotine metabolites should not be used as a
population biomarker when comparing data across differ-
ent countries
Coffee consumption data and the loads of the main
caffeine metabolites in wastewater showed a moderate
correlation between the two data sources. There was,
however, a decent relationship when the observations
from Bristol were removed from the calculations. The
high WBE loads of caffeine measured in Bristol could be
related to the by far highest tea [54], chocolate [55] and
caffeinated energy drinks consumption (also in Spain
[56]). We compared the consumption data with a sum
of all the caffeine metabolites resulting in an even lower
agreement. Other studies have also found that metabol-
ite excretion profiles of caffeine disagree with WBE [7].
This may have different explanations, one being large
variations in caffeine content between different coffee
crops [57].
As described above, there are still a large number of
limitations for both types of epidemiological data. A
precise ecological approach would require data gath-
ered from the same population and at the same time,
but the greatly different time-scales involved in both
approaches and the logistics of sampling make this a
very challenging task.Despite the relatively good agreement with the other
sources of data, it is possible that wastewater data may
be typified by low temporal representativeness and high
spatial variability due to different drug use and availabil-
ity trends from location to location and over time and
therefore, WBE results need to be carefully interpreted.
Thus far, coverage of most of the WBE studies performed
is typically limited to a one-week sampling program, how-
ever, for the future more extensive random-stratified
sampling schemes are recommended to increase the rep-
resentativeness and decrease the level of uncertainty.
Furthermore, because WBE data is an aggregate of the
consumption of all segments of the population, they do
not provide an easy means of assessing the importance of
sex, age or socio-economical information on the findings.
The strength of WBE is however in the ability to more
easily carry out longitudinal studies. Data can be provided
in a more continuous flow rather than the infrequent and
perhaps sporadic data-points that may be generated from
traditional surveys. WBE could therefore prove to be an
excellent source of data for studying the effects of police
operations, education programs or public heath cam-
paigns aimed at reducing the use of a particular drug.
Wastewater analysis and conventional epidemiological
indicators are not expected to be in exact agreement,
but a degree of overlap should exist and be sufficient to
demonstrate the complementary character of these ap-
proaches, as demonstrated by the case studies presented
in this work.
Conclusions
A relatively good relationship between the WBE data
and the other sources of information, especially for
pharmaceuticals and cocaine, was found even with the
limited number of cities in the present study. This
study illustrates that WBE is in reality a snapshot of the
drug situation in a determined location while other
data often are more general, like annual prevalence or
sales data, being less sensitive to quicker changes in the
recent drug use patterns. Further research is needed to
improve the accuracy on the consumption reports and
the uncertainties associated with the WBE. The differ-
ent nature of the datasets can lead to certain disagree-
ment when comparing both sources of information.
Despite this, this work has shown that WBE is cur-
rently providing complementary and valuable informa-
tion to improve the general picture of the drug
situation in Europe. The presented results although
foreseeing a promising future, need to be interpreted
carefully since they provide a rough idea about the level
of agreement between WBE and other sources of data
together with some interesting indicators on the
current drug situation, but both sources are not exempt
from uncertainties.
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